MSCV HAM Myc puro Citations (1)
Originally described in: Evasion of the p53 tumour surveillance network by tumour-derived MYC mutants.Hemann MT, Bric A, Teruya-Feldstein J, Herbst A, Nilsson JA, Cordon-Cardo C, Cleveland JL, Tansey WP, Lowe SW Nature. 2005 Aug 11. 436(7052):807-11. PubMed Journal
Articles Citing MSCV HAM Myc puro
| Articles |
|---|
| c-MYC overexpression overrides TAK1 dependency in efficient tumorigenicity of AKT-transformed cells. Qu Y, Zhang L, Ma A, Zhang F, Li J, Xu D, Yang Z, Qin W, Liu Y. Cancer Lett. 2013 Aug 19;336(2):290-8. doi: 10.1016/j.canlet.2013.03.014. Epub 2013 Mar 21. PubMed |
If you have published an article using this material, please email us at [email protected] to have your article added to this page.